In this episode, Pam Divack sits down with Sarah Emond, President and CEO of ICER (the Institute for Clinical and Economic Review), an independent non-profit research organization that evaluates the evidence on the clinical and economic value of prescription drugs, medical tests, devices, and health system delivery innovations.
They discuss the history of ICER and how it collaborates with stakeholders across the healthcare ecosystem, the key trends and industry pressures giving rise to an increased need for value assessments and comparative effectiveness research, how ICER is working to improve the US Healthcare System, and why this work is critical for aspiring healthcare leaders to track.